Distribuzione geografica
Continente #
NA - Nord America 11333
EU - Europa 3869
AS - Asia 1410
SA - Sud America 16
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 3
AF - Africa 2
Totale 16648
Nazione #
US - Stati Uniti d'America 11296
UA - Ucraina 1450
SE - Svezia 760
TR - Turchia 611
IT - Italia 541
VN - Vietnam 420
CN - Cina 360
FI - Finlandia 349
DE - Germania 257
IE - Irlanda 185
GB - Regno Unito 155
FR - Francia 93
CA - Canada 34
BE - Belgio 33
EU - Europa 15
NL - Olanda 10
BR - Brasile 6
ES - Italia 6
RU - Federazione Russa 6
DK - Danimarca 5
CL - Cile 4
IN - India 4
CH - Svizzera 3
CO - Colombia 3
JP - Giappone 3
MY - Malesia 3
AR - Argentina 2
AU - Australia 2
BG - Bulgaria 2
GR - Grecia 2
IL - Israele 2
LT - Lituania 2
MX - Messico 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EG - Egitto 1
ID - Indonesia 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PL - Polonia 1
RO - Romania 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 16648
Città #
Fairfield 1834
Woodbridge 1128
Jacksonville 1099
Chandler 1089
Houston 827
Seattle 750
Ashburn 743
Wilmington 728
Ann Arbor 659
Cambridge 607
Dearborn 393
Princeton 380
Izmir 352
Nyköping 349
Dong Ket 218
Como 189
Dublin 184
San Mateo 161
San Diego 88
Beijing 69
Milan 66
Hefei 48
Kunming 42
Norwalk 38
Nanjing 34
Brussels 33
Rome 28
Toronto 26
London 23
Ponte Lambro 23
Boardman 21
Nanchang 19
Verona 19
Guangzhou 18
Mcallen 18
Redwood City 18
Kocaeli 17
Düsseldorf 16
Fuzhou 14
Falls Church 13
Jinan 13
Carbonara Al Ticino 12
Chicago 10
Cagliari 8
Ottawa 8
Redmond 8
Shenyang 8
Benevento 7
Chengdu 7
Wuhan 7
Ankara 6
Helsinki 6
Zhengzhou 6
Auburn Hills 5
Chongqing 5
Amsterdam 4
Berlin 4
Bollate 4
Bologna 4
Copenhagen 4
Hebei 4
Istanbul 4
Los Angeles 4
Napoli 4
Phoenix 4
San Giuliano Milanese 4
Shanghai 4
Stuttgart 4
Villanovafranca 4
Changsha 3
Indiana 3
Jinhua 3
Kuala Lumpur 3
Madrid 3
Moscow 3
New York 3
Salerno 3
Siena 3
Simi Valley 3
Stockholm 3
Taizhou 3
Wenzhou 3
Xian 3
Changchun 2
Chaoyang 2
Cinisello Balsamo 2
Clearwater 2
Florence 2
Folignano 2
Fort Worth 2
Groningen 2
Hangzhou 2
Knoxville 2
Lanzhou 2
Lisbon 2
Milazzo 2
Monza 2
Nanning 2
Naples 2
Ningbo 2
Totale 12629
Nome #
Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex 205
Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect 187
Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats 182
Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex 180
New vistas on cannabis use disorder 170
Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2 167
The Depressive Phenotype Induced in Adult Female Rats by Adolescent Exposure to THC is Associated with Cognitive Impairment and Altered Neuroplasticity in the Prefrontal Cortex 163
Assay of GTPγS binding in autoradiography 162
Cannabis abuse in adolescence and the risk of psychosis: A brief review of the preclinical evidence. 161
Long lasting consequences of cannabis exposure in adolescence. 159
Binding of Δ9-tetrahydrocannabinol and diazepam to human serum albumin 157
CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour 156
Transcriptomic and Proteomic Analyses of Mouse Cerebellum Reveals Alterations in RasGRF1 Expression Following In Vivo Chronic Treatment with Delta 9-Tetrahydrocannabinol. 156
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid. 155
Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice 148
Long-term hippocampal glutamate synapse and astrocyte dysfunctions underlying the altered phenotype induced by adolescent THC treatment in male rats. 145
Adolescent exposure to cannabis as a risk factor for psychiatric disorders 143
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex 141
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism 140
Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine 140
Cannabinoids and opioids share cAMP pathway in rat splenocytes 138
A molecular basis of analgesic tolerance to cannabinoids 138
MeCP2 related studies benefit from the use of CD1 as genetic background 133
null 132
Endocannabinoids and Mental Disorders. 132
Expression and function of the endocannabinoid system in glial cells. 129
Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat 129
The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function 129
Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine 126
Role of endocannabinoids in regulating drug dependence 124
Chronic treatment with polychlorinated biphenyls (PCB) during pregnancy and lactation in the rat Part 1: Effects on somatic growth, growth hormone-axis activity and bone mass in the offspring 124
Modulation of rat brain cannabinoid receptors after chronic morphine treatment 123
Cannabinoids and Drugs of abuse 121
Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes 118
Remote memories are enhanced by COMT activity through dysregulation of the endocannabinoid system in the prefrontal cortex 117
Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids. 116
The endocannabinoid system and schizophrenia: integration of evidence. 116
Mice heterozygous for the oxytocin receptor gene (Oxtr(+/-) ) show impaired social behaviour but not increased aggression or cognitive inflexibility: evidence of a selective haploinsufficiency gene effect. 115
Sex-dependent vulnerability to cannabis abuse in adolescence 115
Molecular and cellular basis of cannabinoid and opioid interactions 114
Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats. 114
Pertussis toxin inhibits the antinociceptive action of morphine in the rat.. 114
Adult Cellular Neuroadaptations Induced by Adolescent THC Exposure in Female Rats Are Rescued by Enhancing Anandamide Signaling 113
SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance. 111
Cellular Mechanisms Underlying The Anxiolytic Effect Of Low Doses Of Peripheral D9-Tetrahydrocannabinol In Rats 110
AM630 behaves as a protean ligand at the human cannabinoid CB(2) receptor. 110
Cellular mechanisms underlying the interaction between cannabinoid and opioid system 109
Endocannabinoids and Drug Dependence 109
Sex-dependent changes in brain CB1R expression and functionality and immune CB2R expression as a consequence of maternal deprivation and adolescent cocaine exposure 108
Estrogenic effect of procymidone through activation of MAPK in MCF-7 breast carcinoma cell line 106
Gender-dependent behavioral and biochemical effects of adolescent delta-9-tetrahydrocannabinol in adult maternally deprived rats. 106
Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems 104
Ruolo della via Ras-ERK nella dipendenza ai cannabinoidi 103
Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats 103
Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood 102
Cannabidiol inhibits angiogenesis by multiple mechanisms 102
The endocannabinoid system and psychiatric disorders. 101
Neurobiological mechanisms underlying cannabis-induced memory impairment 101
Cannabimimetic activity, binding, and degradation of stearoylethanolamide within the mouse central nervous system 100
Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw 100
Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia. 100
Binding studies of dermorphin and its L-form on rat brain opioid receptors. 100
Ruolo emergente del sistema degli endocannabinoidi nelle malattie neuropsichiatriche 100
Chronic treatment with the endocannabinoid anandamide increases cytochrome P450 metabolizing system in the rat 99
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors 99
Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain 98
In vivo characterization of the specific cannabinoid receptor antagonist, SR 141716A: behavioral and cellular responses after acute and chronic treatments 98
Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain 98
Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects 98
Influence of pertussis toxin on thermic responses to morphine and neurotensin in rats.. 98
The psychoactive ingredient of marijuana induces behavioural sensitization 97
Endocannabinoids in the immune system and cancer 97
Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940 97
Long-lasting recovery of psychotic-like symptoms in isolation-reared rats after chronic but not acute treatment with the cannabinoid antagonist AM251. 94
Cerebral extract from morphine-tolerant rats shows antiopiate properties in guinea pig ileum bioassay. 94
The phytocannabinoid, delta-9-tetrahydrocannabivarin, can act through 5-HT1A receptors to produce antipsychotic effects 94
Presence and functional regulation of cannabinoid receptors in immune cells 93
Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance - A role for Ras-ERK cascade 93
Central and peripheral components of dermorphin's effect on rat intestinal propulsion in comparison to morphine.. 93
Cholera toxin effects on body temperature changes induced by morphine. 93
Cannabinoids as potential new therapy for the treatment of gliomas. 92
Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. 92
Increase of plasma corticosterone induced by loperamide in rats. 92
Pertussis toxin pretreatment affects opiate/nonopiate and stress-induced analgesia differently. 92
A role of nitric oxide in WIN 55,212-2 tolerance in mice. 91
Presence of a reduced opioid response in interleukin-6 knock out mice 90
Effect on intestinal transit of neurotensin administered intracerebroventricularly to rats. 90
Cannabinoids inhibit nitric oxide production in bone marrow derived feline macrophages 89
Cannabinoids, immune system and cytokine network 89
The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro. 89
Regulation of immune functions in rat splenocytes after acute and chronic in vivo treatment with CP-55,940, a synthetic cannabinoid compound. 88
Chronic cannabinoid, CP-55,940, administration alters biotransformation in the rat. 88
Susceptibility to Psychiatric Diseases After Cannabis Abuse in Adolescence: Animal Models 88
In vivo and in vitro treatment with the synthetic cannabinoid CP55, 940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors 87
Involvement of periaqueductal gray matter in intestinal effect of centrally administered morphine.. 87
null 87
Long-term consequences of URB597 administration during adolescence on cannabinoid CB1 receptor binding in brain areas. 86
Presence of a reduced opioid response in interleukin-6 knock out mice. 86
Changes in rat spleen cannabinoid receptors after chronic CP-55,940: an autoradiographic study. 86
Totale 11574
Categoria #
all - tutte 31022
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31022

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201827 0000 00 00 37116
2018/20192482 71304127 524 50200 34243561809
2019/20204773 223181215994 331536 665586 36232679275
2020/20213189 80340132300 192343 143248 470168295478
2021/20221930 192203182251 5889 7194 94282149265
2022/20232457 265165192326 157582 14381 375000
Totale 16765